Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes.

Abstract

OBJECTIVES:

This study evaluated logistics, process data, and barriers/facilitators for the implementation and use of C-reactive protein point-of-care testing (CRP POCT) for suspected lower respiratory tract infections (LRTIs) in nursing home (NH) residents.

DESIGN:

This process evaluation was performed alongside a cluster randomized, controlled trial (UPCARE study) to evaluate the effect of CRP POCT on antibiotic prescribing for suspected LRTIs in NH residents.

SETTING AND PARTICIPANTS:

Eleven NHs in the Netherlands.

METHODS:

Data sources for process data regarding intervention quality included a questionnaire among NH staff, logs, reports, and CRP POCT-analyzer records. Barriers and facilitators for implementation were assessed in focus group interviews with physicians and nurses from 3 NHs.

RESULTS:

Correct patient selection for CRP POCT and generally continued CRP POCT use indicated good fidelity. The initial training and training of new employees seemed to fit the need, but some POCT-user group sizes had increased over time, which could have impeded frequent use. Users were generally satisfied with CRP POCT and perceived its use feasible and relevant. Facilitators for implementation were initial commitment and active initiation, followed by continued attention and enthusiasm for building routine practice and trust. Short lines of communication between staff, short distance to the POCT-analyzer, 24/7 coverage of staff, and a clear task division facilitated continued attention and routine practice.

CONCLUSIONS AND IMPLICATIONS:

This process evaluation showed sufficient quality of providing CRP POCT in Dutch NHs. We processed findings of intervention quality and implementation knowledge into key recommendations for CRP POCT implementation in this setting. Future research could focus on CRP POCT use in countries with different organization of care in NHs.

• Authors: Tjarda M Boere, Rogier M Hopstaken, Maurits W van Tulder, Franҫois G Schellevis, Theo J M Verheij, Cees M P M Hertogh, Laura W van Buul
• Journal: Journal of the American Medical Directors Association (J Am Med Dir Assoc) Vol. 23 Issue 6 Pg. 968-975.e3 (06 2022) ISSN: 1538-9375 [Electronic] United States
• PMID: 34626578 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Chemical References

• Anti-Bacterial Agents
• C-Reactive Protein

Topics

• Anti-Bacterial Agents (therapeutic use)
• C-Reactive Protein
• Humans
• Nursing Homes
• Point-of-Care Systems
• Point-of-Care Testing
• Respiratory Tract Infections